Amylyx Pharmaceuticals said it would voluntarily remove its FDA-approved drug for amyotrophic lateral sclerosis from the market after a trial showed it doesn’t work. Source link : https://www.washingtonpost.com/business/2024/04/04/amylyx-als-drug/ Author : Daniel Gilbert Publish date : 2024-04-04 15:43:28 Copyright for syndicated content belongs to the linked Source.